Collegium Pharmaceutical, Inc. Common Stock (COLL) — Analysis Summary
Collegium Pharmaceutical, Inc. Common Stock (COLL) has a market cap of $1.09B with year-over-year revenue growth of +11.4%. Net margin stands at 11.0%. The stock trades at a P/E ratio of 15.8.
Key Takeaways
- Revenue changed +11.4% year-over-year
- Net margin of 11.0%
- P/E ratio of 15.8
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, COLL posted revenue growth of +11.4% and trades at a P/E of 15.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.